BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38068934)

  • 21. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
    Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin.
    Jang SK; Hong SE; Lee DH; Kim JY; Kim JY; Hong J; Park IC; Jin HO
    Anticancer Res; 2021 Jul; 41(7):3481-3487. PubMed ID: 34230143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
    Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
    Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer.
    Wang X; Hao Y; Chen J; Ding P; Lv X; Zhou D; Li L; Li L; Xu Y; Zhu Y; Zhang W; Chen L; Liao T; He X; Ji QH; Hu W
    Cell Death Dis; 2023 Jun; 14(6):351. PubMed ID: 37291119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

  • 26. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes.
    Takayama H; Misu H; Iwama H; Chikamoto K; Saito Y; Murao K; Teraguchi A; Lan F; Kikuchi A; Saito R; Tajima N; Shirasaki T; Matsugo S; Miyamoto K; Kaneko S; Takamura T
    J Biol Chem; 2014 Jan; 289(1):335-45. PubMed ID: 24257750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim.
    Sun T; Zhang J; Deng B; Fan X; Long T; Jin H; Tao S; Kang P; Tan Q
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1348-1359. PubMed ID: 33167006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of epidermal growth factor receptor tyrosine kinase inhibitor resistance via Ambra1-mediated autophagy in non-small cell lung cancer.
    Chen YH; Yang Y; Xu LJ; Deng Y; Fu JW
    J Physiol Pharmacol; 2023 Jun; 74(3):. PubMed ID: 37661184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effects of C(2)-ceramide on paclitaxel-induced premature senescence of human lung cancer cells.
    Chen JY; Hwang CC; Chen WY; Lee JC; Fu TF; Fang K; Chu YC; Huang YL; Lin JC; Tsai WH; Chang HW; Chen BH; Chiu CC
    Life Sci; 2010 Sep; 87(11-12):350-7. PubMed ID: 20624405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway.
    Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS
    Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
    Aldonza MB; Hong JY; Bae SY; Song J; Kim WK; Oh J; Shin Y; Lee SH; Lee SK
    PLoS One; 2015; 10(6):e0127841. PubMed ID: 26098947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.
    Wang F; Zhang L; Liu J; Zhang J; Xu G
    Aging (Albany NY); 2020 Jun; 12(11):11042-11060. PubMed ID: 32516753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
    Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X
    Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.
    Wang W; Wang J; Liu S; Ren Y; Wang J; Liu S; Cui W; Jia L; Tang X; Yang J; Wu C; Wang L
    Mol Cancer; 2022 Apr; 21(1):106. PubMed ID: 35477569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1.
    Zhao S; Wu J; Zheng F; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Cell Mol Med; 2015 Mar; 19(3):630-41. PubMed ID: 25598321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.